pimagedine has been researched along with Cognitive Decline in 2 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Zhang, D | 1 |
| Wang, YG | 1 |
| Liu, CY | 1 |
| Wang, ZH | 1 |
| Wang, YF | 1 |
| Li, Q | 1 |
| Song, W | 1 |
| Tian, Z | 1 |
| Wang, P | 1 |
2 other studies available for pimagedine and Cognitive Decline
| Article | Year |
|---|---|
Aminoguanidine ameliorates ovariectomy-induced neuronal deficits in rats by inhibiting AGE-mediated Aβ production.
Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cognitive Dysfunction; Guanid | 2021 |
Aminoguanidine alleviated MMA-induced impairment of cognitive ability in rats by downregulating oxidative stress and inflammatory reaction.
Topics: Amino Acid Metabolism, Inborn Errors; Animals; Animals, Newborn; Antioxidants; Apoptosis; Cognitive | 2017 |